Hinova Pharmaceuticals Inc. (SHA:688302)
China
· Delayed Price · Currency is CNY 50.86
+1.66 (3.37%)
At close: Jul 4, 2025, 2:57 PM CST
Hinova Pharmaceuticals Market Cap
Hinova Pharmaceuticals has a market cap or net worth of 5.04 billion as of July 3, 2025. Its market cap has increased by 93.60% in one year.
Market Cap
5.04B
Enterprise Value
4.26B
Revenue
366.84K
Ranking
n/a
PE Ratio
n/a
Stock Price
50.86
Market Cap Chart
Since April 12, 2022, Hinova Pharmaceuticals's market cap has increased from 2.98B to 5.04B, an increase of 68.97%. That is a compound annual growth rate of 17.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 4, 2025 | 5.04B | 65.61% |
| Dec 31, 2024 | 3.04B | -41.02% |
| Dec 29, 2023 | 5.16B | 29.14% |
| Dec 30, 2022 | 3.99B | 33.95% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 353.48B |
| Shenzhen Mindray Bio-Medical Electronics | 270.66B |
| WuXi AppTec | 202.68B |
| Sichuan Biokin Pharmaceutical | 123.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.67B |
| Aier Eye Hospital Group | 113.31B |
| Shanghai United Imaging Healthcare | 103.67B |
| Yunnan Baiyao Group Co.,Ltd | 99.54B |